Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA, Welch MJ, Dehdashti F. Katzenellenbogen JA, et al. Among authors: dehdashti f. Anticancer Res. 1997 May-Jun;17(3B):1573-6. Anticancer Res. 1997. PMID: 9179196
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.
Dehdashti F, Mortimer JE, Trinkaus K, Naughton MJ, Ellis M, Katzenellenbogen JA, Welch MJ, Siegel BA. Dehdashti F, et al. Breast Cancer Res Treat. 2009 Feb;113(3):509-17. doi: 10.1007/s10549-008-9953-0. Epub 2008 Mar 9. Breast Cancer Res Treat. 2009. PMID: 18327670 Free PMC article.
Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.
Zhao Y, Detering L, Sultan D, Cooper ML, You M, Cho S, Meier SL, Luehmann H, Sun G, Rettig M, Dehdashti F, Wooley KL, DiPersio JF, Liu Y. Zhao Y, et al. Among authors: dehdashti f. ACS Nano. 2016 Jun 28;10(6):5959-70. doi: 10.1021/acsnano.6b01326. Epub 2016 May 18. ACS Nano. 2016. PMID: 27159079 Free PMC article.
Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.
Fowler AM, Clark AS, Katzenellenbogen JA, Linden HM, Dehdashti F. Fowler AM, et al. Among authors: dehdashti f. J Nucl Med. 2016 Feb;57 Suppl 1(Suppl 1):75S-80S. doi: 10.2967/jnumed.115.157933. J Nucl Med. 2016. PMID: 26834106 Free PMC article. Review.
Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.
Chan SR, Fowler AM, Allen JA, Zhou D, Dence CS, Sharp TL, Fettig NM, Dehdashti F, Katzenellenbogen JA. Chan SR, et al. Among authors: dehdashti f. Clin Cancer Res. 2015 Mar 1;21(5):1063-70. doi: 10.1158/1078-0432.CCR-14-1715. Epub 2014 Dec 17. Clin Cancer Res. 2015. PMID: 25520392 Free PMC article.
Advances in positron emission tomographic imaging of lung cancer.
Chen DL, Dehdashti F. Chen DL, et al. Among authors: dehdashti f. Proc Am Thorac Soc. 2005;2(6):541-4, 512. doi: 10.1513/pats.200507-075DS. Proc Am Thorac Soc. 2005. PMID: 16352762 Free PMC article. Review.
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
Dehdashti F, Mortimer JE, Siegel BA, Griffeth LK, Bonasera TJ, Fusselman MJ, Detert DD, Cutler PD, Katzenellenbogen JA, Welch MJ. Dehdashti F, et al. J Nucl Med. 1995 Oct;36(10):1766-74. J Nucl Med. 1995. PMID: 7562040
Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.
Dehdashti F, McGuire AH, Van Brocklin HF, Siegel BA, Andriole DP, Griffeth LK, Pomper MG, Katzenellenbogen JA, Welch MJ. Dehdashti F, et al. J Nucl Med. 1991 Aug;32(8):1532-7. J Nucl Med. 1991. PMID: 1869974
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.
McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, Mintun MA, Katzenellenbogen JA, Welch MJ. McGuire AH, et al. Among authors: dehdashti f. J Nucl Med. 1991 Aug;32(8):1526-31. J Nucl Med. 1991. PMID: 1869973
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.
Dehdashti F, Flanagan FL, Mortimer JE, Katzenellenbogen JA, Welch MJ, Siegel BA. Dehdashti F, et al. Eur J Nucl Med. 1999 Jan;26(1):51-6. doi: 10.1007/s002590050359. Eur J Nucl Med. 1999. PMID: 9933662
169 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback